Pasireotide Diaspartate Patent Expiration
Pasireotide Diaspartate was first introduced by Recordati Rare Diseases Inc
Pasireotide Diaspartate Patents
Given below is the list of patents protecting Pasireotide Diaspartate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Signifor | US7473761 | Somatostatin analogues | Dec 14, 2026 | Recordati Rare |
| Signifor | US8299209 | Pharmaceutical composition comprising cyclic somatostatin analogues | Dec 27, 2025 | Recordati Rare |
| Signifor | US6225284 | Somatostatin peptides |
Jun 28, 2016
(Expired) | Recordati Rare |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Pasireotide Diaspartate's patents.
Latest Legal Activities on Pasireotide Diaspartate's Patents
Given below is the list recent legal activities going on the following patents of Pasireotide Diaspartate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 30 Apr, 2024 | US8299209 |
| Court Processing Terminated | 01 Mar, 2024 | US7473761 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 06 Jul, 2020 | US7473761 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 30 Apr, 2020 | US8299209 |
| Case Docketed to Examiner in GAU Critical | 30 Mar, 2020 | US7473761 |
| Correspondence Address Change Critical | 12 Mar, 2020 | US8299209 |
| Change in Power of Attorney (May Include Associate POA) Critical | 12 Mar, 2020 | US8299209 |
| Patent Term Extension Certificate Critical | 24 Oct, 2017 | US7473761 |
| Case Docketed to Examiner in GAU Critical | 27 Jul, 2017 | US7473761 |
| Notice of Final Determination -Eligible | 11 Jul, 2017 | US7473761 |
Pasireotide Diaspartate's Family Patents
